Vol 2011, No 4 (2011)

Table of Contents

Research & Development

Abbott Becomes Seattle Genetics’ Latest Antibody-Drug Conjugate Collaborator Abstract
Heather Cartwright
Gilead Sciences and Yale School of Medicine in Potential US$100 M Cancer Research Pact Abstract
Heather Cartwright
Pfizer Continues its Pursuit of Rare Disease Therapies with Zacharon Collaboration Abstract
Heather Cartwright
Medtronic and Eli Lilly in Drug-Device Pact for Parkinson’s Disease Abstract
Heather Cartwright

Licensing

Human Genome Sciences Licenses FivePrime Therapeutics’ Lead Cancer Drug Abstract
Heather Cartwright

Mergers & Acquisitions

Quest Diagnostics Aims to Bolster its Genetic Testing Platform with Celera Acquisition Abstract
Heather Cartwright
Cephalon Agrees to Buy Gemin X Pharmaceuticals for up to US$525 M Abstract
Heather Cartwright
Merck & Co. Bolsters its Eye Care Franchise with Inspire Pharmaceuticals Acquisition Abstract
Heather Cartwright
RXi Pharmaceuticals Looks Beyond RNAi Therapeutics with Apthera Acquisition Abstract
Heather Cartwright
Endo to Acquire American Medical Systems and Advance its Diversification Abstract
Heather Cartwright
SciClone Strengthens its Presence in China with NovaMed Acquisition Abstract
Heather Cartwright

Joint Venture

Teva and Procter & Gamble Form Joint Venture to Accelerate OTC Drug Sales Abstract
Heather Cartwright
Merck & Co. Enhances its Emerging Markets Presence with Joint Venture with Sun Pharma Abstract
Heather Cartwright


Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.